Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
| Actual shortage: | 256 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2412 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-AMITRIPTYLINE | 10MG | TABLET | Resolved | 2020-10-01 | 2020-10-24 | 125509 |
| TEVA-TEMOZOLOMIDE | 20MG | CAPSULE | Resolved | 2020-10-01 | 2020-11-07 | 125512 |
| TEVA-DEXTROAMPHETAMINE SR | 10MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2020-10-08 | 2020-10-15 | 126029 |
| TEVA-DOXAZOSIN | 2MG | TABLET | Resolved | 2020-10-08 | 2020-11-19 | 126032 |
| SEASONIQUE | 0.01MG 0.15MG 0.03MG | TABLET | Resolved | 2020-10-08 | 2021-02-25 | 126035 |
| SEASONALE | 0.15MG 0.03MG | TABLET | Resolved | 2020-10-08 | 2021-02-25 | 126038 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2020-10-15 | 2021-03-04 | 126513 |
| ACT RALOXIFENE | 60MG | TABLET | Resolved | 2020-10-15 | 2020-12-03 | 126516 |
| TEVA-AMIODARONE | 200MG | TABLET | Resolved | 2020-10-15 | 2020-11-07 | 126519 |
| TEVA-MELOXICAM | 7.5MG | TABLET | Resolved | 2020-10-15 | 2020-11-26 | 126522 |
| TEVA-OLANZAPINE | 20MG | TABLET | Resolved | 2020-10-15 | 2020-10-30 | 126527 |
| PORTIA 21 | 0.15MG 0.03MG | TABLET | Resolved | 2020-10-15 | 2020-11-26 | 126530 |
| OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2020-10-15 | 2020-11-26 | 126533 |
| ACT RALOXIFENE | 60MG | TABLET | Resolved | 2020-10-22 | 2020-11-26 | 126909 |
| TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2020-10-22 | 2020-12-17 | 126912 |
| TEVA-CLOPIDOGREL | 300MG | TABLET | Resolved | 2020-10-22 | 2020-10-30 | 126915 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2020-10-22 | 2020-11-12 | 126918 |
| TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2020-10-22 | 2020-11-19 | 126921 |
| TEVA-INDOMETHACIN | 50MG | CAPSULE | Resolved | 2020-10-22 | 2020-11-07 | 126924 |
| TEVA-PANTOPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2020-10-22 | 2020-12-17 | 126927 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |